Literature DB >> 3931696

Protection by acyl-carnitines and phenylmethylsulfonyl fluoride of rat heart subjected to ischemia and reperfusion.

W C Hülsmann, M L Dubelaar, J M Lamers, F Maccari.   

Abstract

Perfusion of rat hearts according to the Langendorff technique with micromolar concentrations of palmitoylcarnitine or millimolar concentrations of phenylmethylsulfonyl fluoride protect the heart from deterioration by reperfusion after total-ischemia. This is based on the retention of the cytosolic enzymes determined (lactate dehydrogenase, glycogen phosphorylase and glycogen synthase) and of myoglobin, as well as on the resumption of contractile activity. Palmitoylcarnitine, like phenylmethylsulfonyl fluoride, could protect through plasma membrane stabilization, since more hydrophilic compounds had no effect.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931696     DOI: 10.1016/0167-4889(85)90153-3

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Biochemical profile of propionyl-L-carnitine.

Authors:  W C Hülsmann
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

2.  The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria.

Authors:  R Ferrari; C Ceconi; A Cargnoni; E Pasini; G M Boffa; S Curello; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

3.  Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage.

Authors:  R Ferrari; C Ceconi; S Curello; E Pasini; O Visioli
Journal:  Mol Cell Biochem       Date:  1989 Jun 27-Jul 24       Impact factor: 3.396

4.  Release of ischemia in paced rat Langendorff hearts by supply of L-carnitine: role of endogenous long-chain acylcarnitine.

Authors:  W C Hulsmann; A Peschechera; F Serafini; L E Ferrari
Journal:  Mol Cell Biochem       Date:  1996-03-09       Impact factor: 3.396

5.  Effects of some L-carnitine derivatives on heart membrane ATPases.

Authors:  N S Dhalla; F Kolár; K R Shah; R Ferrari
Journal:  Cardiovasc Drugs Ther       Date:  1991-02       Impact factor: 3.727

6.  Carnitine requirement of vascular endothelial and smooth muscle cells in imminent ischemia.

Authors:  W C Hülsmann; M L Dubelaar
Journal:  Mol Cell Biochem       Date:  1992-10-21       Impact factor: 3.396

7.  Uptake and release of carnitine by vascular endothelium in culture; effects of protons and oxygen free radicals.

Authors:  A Peschechera; L E Ferrari; E Arrigoni-Martelli; W C Hülsmann
Journal:  Mol Cell Biochem       Date:  1995-01-26       Impact factor: 3.396

Review 8.  The Role of l-Carnitine in Mitochondria, Prevention of Metabolic Inflexibility and Disease Initiation.

Authors:  Mohamed Ashraf Virmani; Maria Cirulli
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

9.  The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinases.

Authors:  Phing-How Lou; Eliana Lucchinetti; Liyan Zhang; Andreas Affolter; Marcus C Schaub; Manoj Gandhi; Martin Hersberger; Blair E Warren; Hélène Lemieux; Hany F Sobhi; Alexander S Clanachan; Michael Zaugg
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.